MIRA Pharmaceuticals, Inc.
No trades
No trades
Peers for comparison
−1.3763 USD
−32.00 M USD
0.00 USD
38.69 M
Next report date
Report period
EPS estimate
Revenue estimate
Company info
Sector
Industry
CEO
Erez Aminov
Website
Headquarters
Miami
Founded
2020
IPO date
Aug 3, 2023
ISIN
US60458C1045
CUSIP
60458C104
FIGI
BBG01H8XP5F5
Identifiers
ISIN US60458C1045
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. It engages in developing its product candidates, Ketamir-2 and MIRA-55, designed to address unmet medical needs in pain management, depression, PTSD, and cognitive function. The company was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.
MIRA - Ketamine Biotech Company with massive growth potential!Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suff
MIRA Pharmaceuticals Set to Explode?Overview
MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) has recently demonstrated a notable upward momentum, indicating potential bullish activity. The stock price has surged by 31.45%, closing at $0.8610. This analysis will delve into various technical indicators, price action, and patterns to offer a c
MIRA - LONG
Amid concerns about MIRA Pharmaceuticals' cash burn, there are compelling reasons for optimism. The company has smartly reduced its cash burn by 8.1% in the past year, extending its cash runway to about 16 months as of September 2023. This indicates prudent financial management and a strategic appr
See all ideas
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
Today, MIRA trades at 0.6300 USD.
For broader market analysis, dive into the technicals on the MIRA Pharmaceuticals, Inc. stock price chart and read the latest MIRA news:
– MIRA Pharmaceuticals Inc expected to post a loss of 3 cents a share - Earnings Preview
– MIRA Pharmaceuticals Reports Significant Weight and Fat Reduction With Oral SKNY-1 in Obese Mice, Showing Favorable Lean-Mass and Weight-Regain Outcomes Compared With Semaglutide
– MIRA Pharmaceuticals, Inc. (MIRA) Reports Positive SKNY-1 Obesity Pilot Results
For broader market analysis, dive into the technicals on the MIRA Pharmaceuticals, Inc. stock price chart and read the latest MIRA news:
– MIRA Pharmaceuticals Inc expected to post a loss of 3 cents a share - Earnings Preview
– MIRA Pharmaceuticals Reports Significant Weight and Fat Reduction With Oral SKNY-1 in Obese Mice, Showing Favorable Lean-Mass and Weight-Regain Outcomes Compared With Semaglutide
– MIRA Pharmaceuticals, Inc. (MIRA) Reports Positive SKNY-1 Obesity Pilot Results
Markets don't sleep, here's what's going on with MIRA at the moment:
– MIRA Pharmaceuticals Inc expected to post a loss of 3 cents a share - Earnings Preview
– MIRA Pharmaceuticals Reports Significant Weight and Fat Reduction With Oral SKNY-1 in Obese Mice, Showing Favorable Lean-Mass and Weight-Regain Outcomes Compared With Semaglutide
– MIRA Pharmaceuticals, Inc. (MIRA) Reports Positive SKNY-1 Obesity Pilot Results
See more updates in real-time with our News Flow.
– MIRA Pharmaceuticals Inc expected to post a loss of 3 cents a share - Earnings Preview
– MIRA Pharmaceuticals Reports Significant Weight and Fat Reduction With Oral SKNY-1 in Obese Mice, Showing Favorable Lean-Mass and Weight-Regain Outcomes Compared With Semaglutide
– MIRA Pharmaceuticals, Inc. (MIRA) Reports Positive SKNY-1 Obesity Pilot Results
See more updates in real-time with our News Flow.
MIRA Pharmaceuticals, Inc. is scheduled to release its next earnings report on Dec 2, 2026.
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
MIRA stock is 6.38% volatile and has beta coefficient of 0.63.
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like MIRA are typically less volatile than smaller companies
Track every detail on MIRA Pharmaceuticals, Inc. stock chart and check out the list of the most volatile stocks — is MIRA Pharmaceuticals, Inc. there?
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like MIRA are typically less volatile than smaller companies
Track every detail on MIRA Pharmaceuticals, Inc. stock chart and check out the list of the most volatile stocks — is MIRA Pharmaceuticals, Inc. there?
To understand the MIRA stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — +8.50%
– 1 week — +5.09%
– 1 month — −14.03%
MIRA all-time low was 0.5100 USD (Jul 3, 2024), and its highest price is 7.9799 USD (Aug 3, 2023). Find more dynamics in the Stock Heatmap and on the MIRA Pharmaceuticals, Inc. stock chart.
– 1 day — +8.50%
– 1 week — +5.09%
– 1 month — −14.03%
MIRA all-time low was 0.5100 USD (Jul 3, 2024), and its highest price is 7.9799 USD (Aug 3, 2023). Find more dynamics in the Stock Heatmap and on the MIRA Pharmaceuticals, Inc. stock chart.
MIRA Pharmaceuticals, Inc. market capitalization is 26.01 M, representing the total value of all its outstanding shares (price × shares outstanding).
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from MIRA Pharmaceuticals, Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how MIRA Pharmaceuticals, Inc. stacks up against other companies
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from MIRA Pharmaceuticals, Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how MIRA Pharmaceuticals, Inc. stacks up against other companies
The safest way to buy MIRA Pharmaceuticals, Inc. stocks is through a reliable broker. Create an account, fund it, and place a buy order.
You can trade MIRA directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
You can trade MIRA directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 10, 2026, the company has 2 employees.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Investing in MIRA Pharmaceuticals, Inc. depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.
First, study MIRA Pharmaceuticals, Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our MIRA technicals – signals based on essential indicators calculations:
– Today — neutral
– 1-week — sell
– 1-month — sell
Combine fundamental and technical analysis for better results.
First, study MIRA Pharmaceuticals, Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our MIRA technicals – signals based on essential indicators calculations:
– Today — neutral
– 1-week — sell
– 1-month — sell
Combine fundamental and technical analysis for better results.
MIRA Pharmaceuticals, Inc. stock ticker depends on the exchange where it’s listed. On the NASDAQ, its primary exchange, MIRA Pharmaceuticals, Inc. stocks trade under the symbol MIRA.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
Yes, you can track MIRA Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
MIRA net income for the last quarter is −1.21 M USD, while the quarter before that showed −1.15 M USD of net income which accounts for −5.08% change.
How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result
Follow other essential metrics in MIRA Pharmaceuticals, Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result
Follow other essential metrics in MIRA Pharmaceuticals, Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
No, MIRA Pharmaceuticals, Inc. does not currently pay dividends to its shareholders.
Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.
What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.
What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
MIRA reached its all-time high of 7.9799 USD on Aug 3, 2023. Its all-time low was 0.5100 USD and was reached on Jul 3, 2024.
Explore the MIRA Pharmaceuticals, Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Explore the MIRA Pharmaceuticals, Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Analyst forecasts suggest a price range between 3.50 USD and 9.50 USD for MIRA, based on current estimates.
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance




